Clinical trial

Cardemra in HFpEF: Innovation in a Challenging Population PHARMA DEMO

Endovanta Therapeutics

What is it about?

Cardemra: an investigational sGC stimulator being developed by Endovanta to address the unmet needs of patients with heart failure with preserved ejection fraction (HFpEF).

Who is involved?